A study of safety and immune response to different doses of a cytomegalovirus vaccine in healthy adults

Trial Identifier: 209976
Sponsor: GlaxoSmithKline
Start Date: October 2021
Primary Completion Date: April 2025
Study Completion Date: April 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
UNITED_STATES, CA Anaheim, CA, UNITED_STATES, 92806
UNITED_STATES, CA Long Beach, CA, UNITED_STATES, 90806
UNITED_STATES, CA Los Angeles, CA, UNITED_STATES, 90017
UNITED_STATES, FL Hallandale Beach, FL, UNITED_STATES, 33009
UNITED_STATES, FL Miami, FL, UNITED_STATES, 33143
UNITED_STATES, KY Lexington, KY, UNITED_STATES, 40536-0084
UNITED_STATES, MI Dearborn, MI, UNITED_STATES, 48127
UNITED_STATES, MO Springfield, MO, UNITED_STATES, 65802
UNITED_STATES, NE Lincoln, NE, UNITED_STATES, 68510
UNITED_STATES, NE Omaha, NE, UNITED_STATES, 68134
UNITED_STATES, NJ Newark, NJ, UNITED_STATES, 07103
UNITED_STATES, NJ Secaucus, NJ, UNITED_STATES, 07094
UNITED_STATES, NV Las Vegas, NV, UNITED_STATES, 89109
UNITED_STATES, NY New York, NY, UNITED_STATES, 10065
UNITED_STATES, TX Austin, TX, UNITED_STATES, 78744-1645
UNITED_STATES, TX Cedar Park, TX, UNITED_STATES, 78613
UNITED_STATES, TX Galveston, TX, UNITED_STATES, 77573
UNITED_STATES, WA Puyallup, WA, UNITED_STATES, 98371